Barrett & Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Hold |
2,959
| – | – | 0.21% | 76 |
|
|
2025
Q1 | $620K | Hold |
2,959
| – | – | 0.27% | 66 |
|
|
2024
Q4 | $526K | Buy |
2,959
+12
| +0.4% | +$2.13K | 0.22% | 75 |
|
|
2024
Q3 | $582K | Hold |
2,947
| – | – | 0.25% | 69 |
|
|
2024
Q2 | $505K | Sell |
2,947
-50
| -2% | -$8.58K | 0.23% | 74 |
|
|
2024
Q1 | $546K | Hold |
2,997
| – | – | 0.26% | 67 |
|
|
2023
Q4 | $464K | Sell |
2,997
-49
| -2% | -$7.59K | 0.25% | 78 |
|
|
2023
Q3 | $454K | Buy |
3,046
+1
| +0% | +$149 | 0.27% | 73 |
|
|
2023
Q2 | $410K | Buy |
3,045
+651
| +27% | +$87.7K | 0.24% | 82 |
|
|
2023
Q1 | $382K | Buy |
2,394
+1
| +0% | +$159 | 0.24% | 81 |
|
|
2022
Q4 | $387K | Hold |
2,393
| – | – | 0.26% | 78 |
|
|
2022
Q3 | $387K | Buy |
+2,393
| New | +$387K | 0.26% | 78 |
|